Detalhe da pesquisa
1.
Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120.
J Infect Dis
; 2023 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37795976
2.
Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy.
N Engl J Med
; 379(4): 327-340, 2018 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29897841
3.
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
N Engl J Med
; 379(2): 138-149, 2018 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29996082
4.
Efficacy of high-dose versus standard-dose influenza vaccine in older adults.
N Engl J Med
; 371(7): 635-45, 2014 Aug 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-25119609
5.
Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E.
J Infect Dis
; 207(8): 1195-205, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22837492
6.
Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine.
medRxiv
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38352384
7.
Innate immune cell activation after HIV-1 vaccine administration is associated with increased antibody production.
Front Immunol
; 15: 1339727, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38420129
8.
"Direct and indirect impacts of the COVID-19 pandemic on operational conduct of pediatric vaccine clinical trials".
Hum Vaccin Immunother
; 19(3): 2272535, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942563
9.
Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability.
AIDS
; 37(10): 1519-1524, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37260254
10.
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine.
medRxiv
; 2023 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36523415
11.
ALVAC-HIV and AIDSVAX B/E vaccination induce improved immune responses compared with AIDSVAX B/E vaccination alone.
JCI Insight
; 8(9)2023 05 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154156
12.
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial.
Lancet Respir Med
; 11(11): 975-990, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37716365
13.
Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study.
EClinicalMedicine
; 62: 102109, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37533419
14.
Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study.
EClinicalMedicine
; 64: 102168, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936652
15.
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.
N Engl J Med
; 361(23): 2209-20, 2009 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-19843557
16.
Associations of human leukocyte antigen with neutralizing antibody titers in a tetravalent dengue vaccine phase 2 efficacy trial in Thailand.
Hum Immunol
; 83(1): 53-60, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34635391
17.
Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.
Lancet Infect Dis
; 21(9): 1257-1270, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33887209
18.
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial.
Lancet Infect Dis
; 21(2): 252-262, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32946836
19.
The promise of mRNA vaccines: a biotech and industrial perspective.
NPJ Vaccines
; 5: 11, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32047656
20.
Hybrid clinical trials to generate real-world evidence: design considerations from a sponsor's perspective.
Contemp Clin Trials
; 94: 105856, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31669449